VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
495
New
Increased
Reduced
Closed

Top Buys

1
+$2.11M
2
+$2.09M
3
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

1
+$2.13M
2
+$2.13M
3
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OXSQ icon
251
Oxford Square Capital
OXSQ
$126M
$378K 0.1%
213,488
-9,248
ORIC icon
252
Oric Pharmaceuticals
ORIC
$875M
$368K 0.1%
29,069
+708
VIR icon
253
Vir Biotechnology
VIR
$1.61B
$365K 0.1%
40,759
+995
EWTX icon
254
Edgewise Therapeutics
EWTX
$3.68B
$364K 0.1%
11,544
+281
NCDL icon
255
Nuveen Churchill Direct Lending
NCDL
$645M
$363K 0.1%
28,562
+1,107
XENE icon
256
Xenon Pharmaceuticals
XENE
$5.29B
$360K 0.1%
6,188
+151
NKTR icon
257
Nektar Therapeutics
NKTR
$2.19B
$359K 0.1%
4,984
+121
PCVX icon
258
Vaxcyte
PCVX
$7.42B
$356K 0.1%
6,126
+147
PVLA
259
Palvella Therapeutics
PVLA
$1.7B
$345K 0.1%
2,765
+67
MLTX icon
260
MoonLake Immunotherapeutics
MLTX
$1.41B
$344K 0.09%
18,436
+449
TPVG icon
261
TriplePoint Venture Growth BDC
TPVG
$224M
$342K 0.09%
68,513
-1,069
RLAY icon
262
Relay Therapeutics
RLAY
$3.06B
$338K 0.09%
33,957
+827
ANAB icon
263
AnaptysBio
ANAB
$1.62B
$336K 0.09%
6,067
+148
RVMD icon
264
Revolution Medicines
RVMD
$33.5B
$336K 0.09%
3,454
+83
OFS icon
265
OFS Capital
OFS
$46.5M
$329K 0.09%
92,665
+10,444
PRAX icon
266
Praxis Precision Medicines
PRAX
$9.76B
$326K 0.09%
1,013
+24
CGEM icon
267
Cullinan Oncology
CGEM
$1.01B
$325K 0.09%
22,875
+557
TERN
268
DELISTED
Terns Pharmaceuticals
TERN
$319K 0.09%
6,058
+146
PHVS icon
269
Pharvaris
PHVS
$2.11B
$319K 0.09%
11,286
+275
CAPR icon
270
Capricor Therapeutics
CAPR
$1.74B
$319K 0.09%
10,479
+255
CLDX icon
271
Celldex Therapeutics
CLDX
$2.47B
$314K 0.09%
9,911
+240
LQDA icon
272
Liquidia Corp
LQDA
$5.5B
$308K 0.09%
8,169
+200
BLTE
273
Belite Bio
BLTE
$5.78B
$308K 0.08%
1,929
+47
CTMX icon
274
CytomX Therapeutics
CTMX
$784M
$306K 0.08%
65,080
+1,589
IMNM icon
275
Immunome
IMNM
$2.47B
$305K 0.08%
13,932
+339
9 10
11
12 13